西班牙女性无并发症尿路感染检测和治疗中使用Sysmex PA-100 AST系统作为即时检测的预算影响分析

该数据集提供西班牙女性无并发症尿路感染即时检测(Sysmex PA-100)的预算影响分析结果,包含决策树模型输入及成本节省数据。

Taylor & FrancisTaylor & Francis
DataCite Commons
2026-03-17 更新
浏览 14
表格Budget impact analysispoint of careuncomplicated urinary tract infectionsdetectiontreatmentSpainH61H57
Budget impact analysis on the use of Sysmex PA-100 AST system as a point of care for uncomplicated urinary tract infections detection and treatment in Spanish females

基本信息

模态
表格
大小
0.000054401 GB
许可
CC BY 4.0
创建/更新时间
2026-03-17
版本
v1

资源简介

西班牙女性无并发症尿路感染检测和治疗中使用Sysmex PA-100 AST系统作为即时检测的预算影响分析

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 2 个文件、合计 54.40 KB,主题涵盖 Budget impact analysis、point of care、uncomplicated urinary tract infections、detection、treatment,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Budget impact analysis on the use of Sysmex PA-100 AST system as a point of care for uncomplicated urinary tract infections detection and treatment in Spanish females》。配套论文《Budget impact analysis on the use of Sysmex PA-100 AST system as a point of care for uncomplicated urinary tract infections detection and treatment in Spanish females》发表于 Journal of Medical Economics(2024),DOI:10.1080/13696998.2024.2420534。源站首次发布:2024-10-23。

【数据内容】

源站原始描述:Efficient diagnostic methods, such as the Sysmex PA-100, provide rapid antimicrobial susceptibility test results directly from urine samples with high sensitivity and specificity, and improve treatment recommendations. Our study analyzes the economic impact of integrating the Sysmex PA-100 to assess its potential benefits and cost implications for uncomplicated urinary tract infection (uUTI) management in Spain. A budget impact model was developed using a decision tree framework to compare curre…

中文译文(机器翻译,仅供快速理解,请以原文为准):高效的诊断方法,如Sysmex PA-100,可直接从尿液样本中快速提供抗菌药物敏感性试验结果,具有高灵敏度和特异性,并改善治疗建议。本研究分析了整合Sysmex PA-100的经济影响,以评估其在西班牙非复杂性尿路感染(uUTI)管理中的潜在获益和成本影响。 采用决策树框架开发了预算影响模型,以比较当前的尿路感染管理实践与纳入Sysmex PA-100的新情景。临床输入数据提取自已发表文献。该模型以患有uUTI的成年女性为对象,评估了三年内的直接医疗成本和间接成本,包括诊断程序、治疗成本、员工时间成本以及生产力损失。成本数据来自西班牙两家医院。模型中进行了两种情景分析:情景A纳入了接受不必要经验性抗生素治疗的患者中抗菌药物耐药性(AMR)出现的成本,而情景B假设无AMR成本。 在情景A中,一年内在西班牙各医疗机构100%实施PA-100可带来总成本节约323,657,712欧元(每名患者每年119.10欧元)。三年内实施PA-100所带来的总成本节约为970,973,137欧元。在情景B中,年度总节约为4,254,795欧元(每名患者每年1.57欧元),三年节约为12,764,385欧元。 采用该床旁检测系统可实现总体成本节约,这主要得益于尿路感染管理相关直接和间接成本的降低。该模型强调了三年内由于适当的快速管理(缩短诊断和治疗时间,从而减少并发症和继发感染)以及减少员工时间和生产力损失成本所带来的潜在节约。这些发现支持采用Sysmex PA-100以加强西班牙尿路感染管理和优化医疗资源配置的潜在获益。

【数据结构与技术规格】

文件数 2 个,合计 54.40 KB。ijme_a_2420534_sm6715.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,29.98 KB。ijme_a_2420534_sm1224.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,24.42 KB。数据集 DOI:10.6084/m9.figshare.27282647.v1。

【主题与分类】

源站学科分类:Medicine、Ecology、Immunology、Biological Sciences not elsewhere classified、Science Policy、Infectious Diseases。主题标签:Budget impact analysis、point of care、uncomplicated urinary tract infections、detection、treatment、Spain、H61、H57。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Budget_impact_analysis_on_the_use_of_Sysmex_PA-100_AST_system_as_a_point_of_care_for_uncomplicated_urinary_tract_infections_detection_and_treatment_in_Spanish_females/27282647

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Budget impact analysis on the use of Sysmex PA-100 AST system as a point of care for uncomplicated urinary tract infections detection and treatment in Spanish females. Taylor & Francis. Elsisi, Gihan Hamdy; Zaky, Hanan Saady; Polo, José Medina

【使用注意】

· 源站最后修改于 2026-03-17,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ijme_a_2420534_sm6715.docx" "https://ndownloader.figshare.com/files/49936511"
curl -L -o "ijme_a_2420534_sm1224.docx" "https://ndownloader.figshare.com/files/49936514"

文件清单

  • ijme_a_2420534_sm6715.docx(29.98 KB)
  • ijme_a_2420534_sm1224.docx(24.42 KB)

文件总体积 54.40 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Efficient diagnostic methods, such as the Sysmex PA-100, provide rapid antimicrobial susceptibility test results directly from urine samples with high sensitivity and specificity, and improve treatment recommendations. Our study analyzes the economic impact of integrating the Sysmex PA-100 to assess its potential benefits and cost implications for uncomplicated urinary tract infection (uUTI) management in Spain.
A budget impact model was developed using a decision tree framework to compare current UTI management practices with a new scenario incorporating the Sysmex PA-100. The clinical inputs were extracted from published literature. The model, representing adult females with uUTIs, assessed direct medical and indirect costs over three years, including diagnostic procedures, treatment costs, staff time costs, and productivity loss. The cost data was captured from two Spanish hospitals. Two scenario analyses were conducted in the model: scenario A included costs for antimicrobial resistance (AMR) emergence in patients receiving unnecessary empirical antibiotics, whereas scenario B assumed no AMR costs.
In scenario A, 100% implementation of PA-100 within various Spanish healthcare settings over one year resulted in total cost savings of EUR 323,657,712 (EUR 119.10 per patient per year). The total overall cost savings attributable to the implementation of PA-100 over three years were EUR 970,973,137. In scenario B, the total annual savings were EUR 4,254,795 (EUR 1.57 per patient per year), and the 3-year savings were EUR 12,764,385.
The adoption of this point-of-care system results in overall cost savings, driven by reductions in direct and indirect costs related to UTI management. The model highlights potential savings over three years owing to appropriate rapid management (reduction in time to diagnosis and treatment, which leads to fewer complications and secondary infections) and reduced staff time and productivity loss costs. These findings support the potential benefits of adopting the Sysmex PA-100 to enhance UTI management and allocate healthcare resource utilization in Spain.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.27282647.v1(source: https://tandf.figshare.com/articles/dataset/Budget_impact_analysis_on_the_use_of_Sysmex_PA-100_AST_system_as_a_point_of_care_for_uncomplicated_urinary_tract_infections_detection_and_treatment_in_Spanish_females/27282647)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案